Detalhe da pesquisa
1.
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
J Immunol
; 196(1): 284-97, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26608924
2.
GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults.
Nat Commun
; 14(1): 3274, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280238
3.
Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.
Nat Commun
; 13(1): 3289, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672369
4.
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells.
Int Immunopharmacol
; 66: 296-308, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30502651
5.
CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.
J Clin Invest
; 119(9): 2564-76, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19726873